The Recall Desk
Agency classClass IIOur severity:ModerateFDA (Devices)·Z-1348-2022·Announced 2022-07-20

CoolCurve ZELTIQ vacuum applicators withdrawn due to increased Paradoxical Hyperplasia complaints

Zeltiq Aesthetics is removing 703 CoolCurve ZELTIQ vacuum applicators due to increased complaints of Paradoxical Hyperplasia reported between 2019 and 2021.

The agency’s classification

FDA (Devices): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 2/5 (Moderate).

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: FDA Class II recall initiated as a voluntary discontinuation due to increased complaint rate for Paradoxical Hyperplasia during 2019–2021. No hospitalizations, serious injuries, or deaths are documented; the action represents a precautionary product removal based on increased adverse event reports.

Plain-English summary

Zeltiq Aesthetics, Inc. is voluntarily discontinuing and removing the CoolCurve ZELTIQ Vacuum Applicator (REF BRZ-AP1-062-000) from use. This aesthetic medical device was designed for non-surgical fat reduction using cooling technology.

The company initiated this recall due to an increase in complaint rates for the adverse event Paradoxical Hyperplasia (HP), which occurred during the 2019 to 2021 timeframe. Paradoxical Hyperplasia is characterized by abnormal fat tissue growth in the treated area following the procedure.

Approximately 703 units of the affected product were distributed in the United States and internationally, including in countries such as Canada, the United Kingdom, Australia, Japan, and numerous others.

Users of the CoolCurve ZELTIQ vacuum applicators are advised to discontinue use and contact Zeltiq Aesthetics for guidance on product removal and any necessary patient follow-up regarding potential Paradoxical Hyperplasia.

The recalled product

Product
CoolCurve ZELTIQ Vaccum Applicator REF BRZ-AP1-062-000
Affected units
703

Distribution

Part of a larger recall action

This product is one of 5 recalled by Zeltiq Aesthetics, Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 5 products in this recall →

Similar recalls